CD55 anticorps
Aperçu rapide pour CD55 anticorps (ABIN120605)
Antigène
Voir toutes CD55 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Réactivité croisée (Details)
- Species reactivity (tested):Human, non-Human Primates
-
Purification
- Precipitation Methods and Size-Exclusion Chromatography
-
Immunogène
- HPB-ALL human T cell line
-
Isotype
- IgM
-
-
-
-
Indications d'application
-
Flow Cytometry. Immunoprecipitation. Immunohistochemistry (paraffin sections) Recommended dilution: 10 m g/mL
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS, pH ~7.4 with 15 mM Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
-
Store the antibody at 2 - 8 °C. Do not freeze.
Shelf Life: one year from despatch. -
Date de péremption
- 12 months
-
-
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
Autre désignation
- CD55 / DAF
-
Sujet
- CD55 (decay-accelerating factor, DAF) is a GPI-anchored membrane glycoprotein that protects autologous cells from classical and alternative pathway of complement cascade. Bidirectional interactions between CD55 and CD97 are involved in T cell regulation and CD55 can still regulate complement when bound to CD97. In tumours, besides protection agains complement, CD55 promotes neoangiogenesis, tumorigenesis, invasiveness and evasion of apoptosis.Synonyms: Complement decay-accelerating factor
-
UniProt
- P08174
-
Pathways
- Système du Complément, Regulation of Leukocyte Mediated Immunity
Antigène
-